Health effects of nutrients and environmental pollutants in Baltic herring and salmon: a quantitative benefit-risk assessment

被引：0
|
作者：
Jouni T. Tuomisto
Arja Asikainen
Päivi Meriläinen
Päivi Haapasaari
机构：
[1] Finnish Institute for Health and Welfare,
[2] University of Helsinki,undefined
来源：
BMC Public Health | / 20卷
关键词：
Fish consumption; Dioxins; Methylmercury; Benefit-risk assessment; Health impact; Sperm concentration; Baltic Sea; Knowledge crystal; Food recommendation; European food safety authority EFSA;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [21] Application of Quantitative Methodologies for Benefit-Risk Assessment: Case Study with Rosiglitazone and Pioglitazone
    Mendes, Diogo
    Alves, Carlos
    Marques, Francisco Batel
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 462 - 463
  • [22] A systematic review of models used in quantitative benefit-risk assessment of rotavirus vaccination
    Arlegui, Hugo
    Nachbaur, Gaelle
    Begaud, Bernard
    Praet, Nicolas
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 491 - 491
  • [23] Methodological guidelines and publications of benefit-risk assessment for health technology assessment: a scoping review
    Suzumura, Erica Aranha
    de Oliveira Ascef, Bruna
    Maia, Fernando Henrique de Albuquerque
    Bortoluzzi, Aline Frossard Ribeiro
    Domingues, Sidney Marcel
    Farias, Natalia Santos
    Gabriel, Franciele Cordeiro
    Jahn, Beate
    Siebert, Uwe
    de Soarez, Patricia Coelho
    BMJ OPEN, 2024, 14 (06):
  • [24] Benefit-Risk Assessment of Vaccines. Part I: A Systematic Review to Identify and Describe Studies About Quantitative Benefit-Risk Models Applied to Vaccines
    Arlegui, Hugo
    Bollaerts, Kaatje
    Salvo, Francesco
    Bauchau, Vincent
    Nachbaur, Gaelle
    Begaud, Bernard
    Praet, Nicolas
    DRUG SAFETY, 2020, 43 (11) : 1089 - 1104
  • [25] Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC)
    Arlegui, Hugo
    Bollaerts, Kaatje
    Bauchau, Vincent
    Nachbaur, Gaelle
    Begaud, Bernard
    Praet, Nicolas
    DRUG SAFETY, 2020, 43 (11) : 1105 - 1120
  • [26] Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC)
    Hugo Arlegui
    Kaatje Bollaerts
    Vincent Bauchau
    Gaëlle Nachbaur
    Bernard Bégaud
    Nicolas Praet
    Drug Safety, 2020, 43 : 1105 - 1120
  • [27] Value Assessment and Quantitative Benefit-Risk Modelling of Biosimilar Infliximab for Crohn’s Disease
    Heather Catt
    Keith Bodger
    Jamie J. Kirkham
    Dyfrig A. Hughes
    PharmacoEconomics, 2019, 37 : 1509 - 1523
  • [28] Value Assessment and Quantitative Benefit-Risk Modelling of Biosimilar Infliximab for Crohn's Disease
    Catt, Heather
    Bodger, Keith
    Kirkham, Jamie J.
    Hughes, Dyfrig A.
    PHARMACOECONOMICS, 2019, 37 (12) : 1509 - 1523
  • [29] Methodological guidelines and publications of benefit-risk assessment for health technology assessment: a scoping review protocol
    Ascef, Bruna De Oliveira
    Gabriel, Franciele Cordeiro
    Suzumura, Erica Aranha
    Maia, Fernando Henrique de Albuquerque
    Bortoluzzi, Aline Frossard Ribeiro
    Farias, Natalia Santos
    Jahn, Beate
    Siebert, Uwe
    De Soarez, Patricia Coelho
    BMJ OPEN, 2023, 13 (12):
  • [30] Effects of air pollutants on the environmental health risk assessment of Gyeongju and Pohang in South Korea
    Jung, Jong-Hyun
    Shon, Byung-Hyun
    Yoo, Kyung-Seun
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
12345